Benzazepine platelet aggregation inhibitors having specificity for the GPII.sub.b III.sub.a receptor
US5403836A · kind A · utility
24Cited by
10References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 6, 1993 |
| Grant date | Apr 4, 1995 |
| Priority date | — |
| Expiry date | May 6, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D267/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A benzazepine derivative that acts as a nonpeptidyl platelet aggregation inhibitor is provided. This inhibitor potently inhibits fibrinogen binding to the GPII.sub.b III.sub.a receptor and is provided in therapeutic compositions for the treatment of diseases for which blocking platelet aggregation is indicated. These nonpeptidyl inhibitors are provided in combination with thrombolytics and anticoagulants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.